Kipel 5mg Chewable Tablets - 30's
HomeMedicineKipel 5mg Chewable Tablets - 30's

Kipel 5mg Chewable Tablets - 30's

Last reviewed: May 20, 2026
  • Formulated with montelukast sodium selective leukotriene receptor antagonist asthma controller.
  • Indicated for daily prophylaxis and chronic maintenance management of asthma.
  • Monitor patients closely for potential severe treatment-induced neuropsychiatric behavioral changes.
45,000Tsh/ Unit
1

Welcome Back

Or continue with

Not a member yet? |